APOLLOHOSP stock news on Anadi Algo News

Monday, June 15, 2026
DISCLAIMER: AI-generated signals are for informational purposes only. All trading and investment decisions are solely the user's responsibility.|Past performance does not guarantee future results. Trade at your own risk.|Anadi Algo is not a SEBI-registered advisor. Consult a qualified financial advisor before acting on any recommendation.|DISCLAIMER: AI-generated signals are for informational purposes only. All trading and investment decisions are solely the user's responsibility.|Past performance does not guarantee future results. Trade at your own risk.|Anadi Algo is not a SEBI-registered advisor. Consult a qualified financial advisor before acting on any recommendation.|
Stock Landing|62 matching stories

APOLLOHOSP Share Price, Latest News & Sentiment

Latest AI-analyzed news for APOLLOHOSP, along with saved share-price context, sentiment, quarterly filing summary, and related names in one page.

Stock Coverage Hub

APOLLOHOSP News Today

Large-cap stock hub

Regulatory scrutiny on healthcare practices is increasing, impacting revenue models. This directive highlights a shift towards greater patient autonomy and transparency in drug procurement.

Coverage
62
recent stories
Sources
5
distinct publishers
Bias Split
51 bullish / 5 bearish
4 neutral stories
Window
95d
recent coverage span
Saved Quote Snapshot

APOLLOHOSP

Last Updated
23 May 2026
Price
NA
NA
52W Range
NA - NA
exchange snapshot
PE / VWAP
PE NA
VWAP NA
Trend Read
bullish
Bullish stack · EMA 5 > 9 > 21 > 50
Business Context
Industry: NA
Sector Trail: NA
Listing Date: NA
Market Structure
F&O Eligible: No
Indices: NA
Snapshot Source: mcp+nse
Quarterly Read

Quarter ended 31 Dec 2024

Consolidated results
What This Quarter Says

This is the latest financial report for Apollo Hospitals. The company made ₹5526.9 crore in sales and ₹374.1 crore in profit. This information is on record for your review.

Revenue
Rs 5,527 cr
up 169.0% vs previous filing
Profit
Rs 374.1 cr
up 9.5% vs previous filing
EPS / Finance Cost
EPS 25.89
Finance cost Rs 109.8 cr
Filing Context
Filed 11 Feb 2025, 8:01 pm
Figures are taken from the saved exchange filing, not from a live request.
Quick Reader Notes
  • Revenue this quarter: Rs 5,527 cr, up 169.0% vs previous filing.
  • Profit this quarter: Rs 374.1 cr, up 9.5% vs previous filing.
  • EPS gives a quick sense of per-share earnings: 25.89.
How To Read This

Treat this block as a saved quarter snapshot. First see whether revenue and profit are improving, then read the latest news below to judge whether recent headlines support that trend or work against it.

APOLLOHOSP FAQ

Why is APOLLOHOSP in the news right now?

APOLLOHOSP has appeared across 62 recent stories from 5 sources, which usually means there is a real flow of fresh headlines rather than a single isolated mention.

Is APOLLOHOSP coverage bullish or bearish right now?

APOLLOHOSP coverage is currently leaning bullish, with 51 bullish, 5 bearish, and 4 neutral analyzed stories in the recent window.

Which themes are moving with APOLLOHOSP?

Recent APOLLOHOSP coverage is clustering around Healthcare and Pharmaceuticals. Related names showing up alongside APOLLOHOSP include FORTIS, MAXHEALTH, DRL.

How should I use this APOLLOHOSP news page?

Use this page as a coverage hub for APOLLOHOSP: start with the latest headlines, then check the dominant themes, related names, and saved market context before you form a trade or watchlist view.

Workflow View

Use APOLLOHOSP coverage to build a cleaner watchlist.

A stock page is most useful when it helps you slow down, compare headlines, and separate one-off noise from a repeatable setup.

This is here if you want to go deeper, not as a push.Explore Anadi
Consider a bearish bias for hospital stocks with high pharmacy revenue contribution, with risk managed by monitoring regulatory enforcement and company-specific disclosures.

Latest APOLLOHOSP Stock Coverage

Maintain a bullish bias on established hospital stocks, looking for entry points on minor pullbacks, with a focus on companies demonstrating strong balance sheets and expansion capabilities.|Quick check: APOLLOHOSP neutral (-0.4% 1d), FORTIS neutral (+1.3% 1d).
Maintain a bullish bias on quality hospital stocks; look for entry points on dips, with a focus on companies with strong balance sheets and expansion plans. Implement strict stop-losses.|Quick check: APOLLOHOSP bullish bias (+2.2% 1d), FORTIS bearish bias (oversold).
Maintain a bullish bias on listed hospital chains and the broader healthcare sector.|Quick check: APOLLOHOSP bullish bias (+2.2% 1d), FORTIS bearish bias (oversold).
Maintain a neutral to slightly positive bias on specialized healthcare providers, watching for M&A catalysts and valuation shifts.|Quick check: APOLLOHOSP neutral (+0.5% 1d), TCS bullish bias (overbought).
Observe price direction with volume; high volume on up move is bullish, on down move is bearish.|Quick check: APOLLOHOSP neutral (-0.8% 1d), NIFTY bearish bias (-27.5% 1d).
No trade setup possible from this article.|Quick check: APOLLOHOSP bullish bias (+0.0% 1d), NIFTY bearish bias (oversold).
Consider a 'buy on dips' strategy for fundamentally strong stocks within these performing sectors, maintaining strict stop-losses.|Quick check: GRASIM bullish bias (overbought), VBL bullish bias (+4.0% 1d).
Consider long positions with strict stop-losses, targeting intraday gains.|Quick check: APOLLOHOSP bullish bias (overbought), KEI bullish bias (+2.0% 1d).
Maintain a bullish bias on healthcare stocks with strong balance sheets and strategic growth initiatives; consider long positions in APOLLOHOSP.|Quick check: APOLLOHOSP bullish bias (overbought), TCS bearish bias (-0.3% 1d).
Maintain a bullish bias on established hospital chains with strong balance sheets and clear expansion strategies, focusing on long-term growth potential.|Quick check: APOLLOHOSP bullish bias (overbought), SUNPHARMA bullish bias (-0.1% 1d).
Maintain a bullish bias on leading hospital stocks, focusing on companies with strong balance sheets and consistent growth. Look for entry points on minor pullbacks.|Quick check: APOLLOHOSP bullish bias (overbought), MARUTI bearish bias (-0.0% 1d).
Consider a long position in APOLLOHOSP, with a stop-loss below recent support levels, targeting further upside based on strong fundamentals.|Quick check: APOLLOHOSP bullish bias (overbought), MARUTI bearish bias (-0.0% 1d).
Consider a long bias on established healthcare players with strong fundamentals, but be mindful of potential increased competition from new entrants like Bajaj.|Quick check: BAJAJFINSV neutral (+1.6% 1d), BAJFINANCE neutral (-0.3% 1d).
For auto stocks, look for commentary on volume growth, commodity cost trends, and EV transition plans. Trade with a bias towards companies showing resilience in margins and strong order books, maintaining strict stop-losses.|Quick check: GRASIM neutral (-0.9% 1d), MOTHERSON bullish bias (overbought).
Bullish bias for NATIONALUM, APOLLOHOSP, NTPC; look for entry points with risk management.|Quick check: NATIONALUM neutral (+1.9% 1d), APOLLOHOSP bullish bias (overbought).
Positive bias for Bajaj Group entities; neutral to slightly cautious for existing healthcare providers due to new competition.|Quick check: BAJAJFINSV bearish bias (+0.8% 1d), APOLLOHOSP bullish bias (overbought).
Maintain a bullish bias on established Indian hospital chains, looking for opportunities to accumulate on price corrections, with a focus on long-term growth potential.|Quick check: FORTIS bullish bias (overbought), APOLLOHOSP bullish bias (overbought).
Positive bias for companies innovating in medical technology and healthcare services.|Quick check: APOLLOHOSP bullish bias (overbought), FORTIS bullish bias (overbought).
Consider long positions in fundamentally strong power utilities and healthcare stocks, with a strict stop-loss given the volatile macro environment.|Quick check: NLCINDIA bullish bias (overbought), APOLLOHOSP bullish bias (overbought).
Maintain a bullish bias on hospital stocks, focusing on companies with strong balance sheets and proven expansion plans, with a disciplined stop-loss below key support levels.|Quick check: APOLLOHOSP bullish bias (overbought), FORTIS neutral (+0.0% 1d).
Positive bias for these specific stocks; look for continuation patterns or consolidation before further upside.|Quick check: BAJAJ-AUTO bullish bias (overbought), NESTLEIND bullish bias (overbought).
No specific trade setup without knowing the beta value, but use it to gauge market sensitivity.|Quick check: APOLLOHOSP neutral (-0.1% 1d), NIFTY neutral.
Bearish outlook for private hospital stocks, as revenue streams from government schemes are under threat.|Quick check: APOLLOHOSP neutral (-0.1% 1d), TATASTEEL bullish bias (+1.9% 1d).
Consider long positions in IT companies with strong healthcare verticals or health-tech startups.|Quick check: APOLLOHOSP neutral (-0.1% 1d), INDUSINDBK bullish bias (overbought).
Maintain a bullish bias on hospital stocks; look for accumulation opportunities on minor pullbacks, with a focus on companies demonstrating strong expansion plans and operational efficiency.|Quick check: APOLLOHOSP bullish bias (+1.9% 1d), NARAYANAHRU neutral.
Neutral for energy stocks; focus remains on crude/gas price movements and regulatory changes.|Quick check: NESTLEIND bullish bias (overbought), DABUR bullish bias (overbought).
Maintain a bullish bias on hospital stocks; look for entry points on minor pullbacks, with a focus on companies demonstrating strong execution and capacity utilization.|Quick check: MAXHEALTH bullish bias (overbought), APOLLOHOSP bullish bias (overbought).
Maintain a bullish bias on listed hospital chains, looking for opportunities in companies with strong growth prospects or M&A potential.|Quick check: APOLLOHOSP bullish bias (overbought), FORTIS bullish bias (overbought).
Bullish for the long-term healthcare sector; mixed for existing players due to increased competition.|Quick check: BAJAJFINSV neutral (-0.7% 1d), APOLLOHOSP neutral (-0.1% 1d).
Consider long positions in diagnostic chains and hospital stocks, as corporate focus on employee health drives demand for preventive care services.
Consider long positions in healthcare providers and health insurance companies, as universal insurance could drive significant sector growth.
Bullish for Indian pharma and healthcare stocks; monitor companies with potential to enter or expand in the weight-loss drug and wellness market.
Monitor progress on India-US bilateral trade talks for potential long-term bullish catalysts in export-oriented sectors like IT, textiles, and pharmaceuticals.
Monitor pharmacy chain operators for potential margin pressure due to increased compliance costs; market has likely priced in some of this given the article's age.
Monitor progress on India-US trade negotiations; positive developments could signal buying opportunities in export-oriented Indian IT, textile, and pharmaceutical stocks.
The market has likely priced in some of this news given its age; however, watch for specific sector-wise announcements and stock-specific reactions upon official FTA signing for potential upside in export-oriented companies.
Monitor the broader healthcare IT and BPO sector for potential upside, as this IPO signals strong investor appetite.
Consider long-term accumulation in infrastructure, healthcare, and agriculture-related stocks, as Japanese funding signals sustained growth in these sectors.
Monitor the Indian healthcare sector for increased investor interest and potential IPO pipeline, while keeping an eye on domestic investment banks for competitive pressures.
Bullish for Indian healthcare and pharmaceutical stocks; consider long-term positions in hospital chains, diagnostic labs, and pharma companies focused on lifestyle diseases.
Consider long positions in established Indian hospital chains, diagnostic companies, and pharmaceutical majors, as the sector's long-term growth trajectory remains strong despite financing hurdles.
Monitor the IPO progress of Manipal Health as it could set a positive valuation benchmark for listed hospital stocks; consider long positions in established hospital chains.
Bullish for the Indian hospital sector; consider long positions in established players like Apollo Hospitals, Fortis, and Max Healthcare, anticipating sector re-rating.
Bullish for Indian healthcare stocks; consider long positions in established pharma, hospital, and diagnostic chains with a focus on affordable segments.
Market has likely priced in some of this, but look for sector-specific breakouts in export-oriented IT, auto, and textile stocks as implementation details emerge.
Focus on export-oriented Indian companies, particularly in IT, textiles, and pharmaceuticals, as they stand to benefit from enhanced market access to the UK and EU.
Monitor WTO outcomes for specific policy changes in e-commerce, agriculture, and fisheries; these could create long-term directional biases for related Indian export sectors.
Long-term bullish outlook for Indian health insurance and healthcare providers; consider accumulating quality stocks in these sectors on dips.
Consider short positions or reducing exposure in FMCG, footwear, and healthcare stocks reliant on plastic inputs, while petrochemical producers like Reliance may see short-term gains.
Consider long positions in Indian generic pharmaceutical companies and hospital chains, as the obesity treatment market is set for significant expansion.
Consider long positions in hospital chains and pharmaceutical companies with oncology portfolios, anticipating increased government healthcare spending.
Market has likely priced this in given the article age; however, continued reduction in promoter pledges across Nifty200 stocks remains a long-term bullish indicator for individual companies.
Monitor hospital sector stocks for increased volatility and potential consolidation plays; focus on leaders with strong balance sheets.
Consider long positions in hospital stocks, especially those with expansion plans in Tier II/III cities, given the strong underlying demand and analyst confidence.
Consider these stocks for long-term portfolio allocation, but conduct fresh due diligence given the article's age and current market conditions.
Market has likely priced this in; however, monitor specific export-oriented stocks for sustained positive sentiment if concrete schemes are announced.